DB-0646

Target: DB-0646 targets multiple kinases as a broad chemoproteomic degrader scaffold.

Binding site: Its promiscuous kinase ligand engages ATP-competitive kinase catalytic pockets.

Mechanism of action: DB-0646 is a PROTAC-based multi-kinase degrader developed for mapping degradable kinome susceptibility. It contains a broad-spectrum kinase-binding moiety connected to an E3 ligase-recruiting ligand through a flexible linker, allowing multiple kinases to be tested for proximity-induced ubiquitination and proteasomal degradation. Rather than serving as a single-target probe, DB-0646 is most useful for discovery-oriented profiling of kinase degradability, ternary-complex compatibility, and degradation selectivity. It supports studies of kinase signaling networks, target prioritization, and structure-guided development of more selective kinase degraders.

• PROTAC-Mediated Kinase Degradation: DB-0646 is employed in the selective degradation of kinases, facilitating the study of kinase-dependent signaling pathways. By harnessing the ubiquitin-proteasome system, researchers can dissect complex cellular processes and identify potential therapeutic targets through the precise elimination of specific kinase proteins.

• Targeted Protein Degradation in Cancer Research: Utilizing DB-0646 enables the targeted degradation of oncogenic proteins, offering a valuable tool for cancer biology studies. This approach allows scientists to investigate the role of specific proteins in tumor progression and resistance mechanisms, advancing the development of novel cancer treatment strategies.

• PROTAC-Based Neurodegenerative Disease Models: DB-0646 is instrumental in creating models for neurodegenerative diseases by targeting and degrading proteins implicated in neuronal dysfunction. This application aids in unraveling disease mechanisms and evaluating potential therapeutic interventions, providing insights into protein homeostasis in neuronal health and disease.

• Selective Protein Knockdown for Functional Studies: DB-0646 facilitates the selective knockdown of target proteins, enabling researchers to perform functional studies with high specificity. This approach aids in elucidating protein function, interactions, and pathways, enhancing our understanding of cellular biology and the identification of novel drug targets.